12 September 2017
A new system being developed by Cambridge Cognition with Innovate UK funding will provide a non-invasive, inexpensive means of accurately monitoring levels of pain by combining artificial intelligence technology and cognitive neuroscience.
17 August 2017
Evolocumab Phase 3 Cognitive Function Study Results Published in the New England Journal of Medicine
Cambridge Cognition and Amgen announce that the New England Journal of Medicine (NEJM) published results from the evolocumab cognitive function trial, which was conducted in a subset of patients enrolled in the randomized, placebo-controlled evolocumab cardiovascular outcomes study.
10 July 2017
Cambridge Cognition is attending the Alzheimer's Association International Conference in London.
13 June 2017
The 2017 CANTAB Research Grant was once again overwhelmed with applications. All the research proposals received were such high quality it was another impossible task for our funding committee to review and narrow the proposals down. We received applications from across the globe from Hong Kong to Saint Lucia. But there could only be 3 awards.
7 June 2017
Cambridge Cognition is pleased to announce its application of automatic speech recognition (“ASR”) technology to develop new products to enable scalable, language-based clinical assessment to reduce clinical trial variability and costs and increase overall clinical trial efficiency.
19 May 2017
During a week focusing on employment skills, businesses were invited to Cambridge Regional College (CRC) to talk to students during its Computer Industry Week, running practical workshops on interview preparation and skills.
16 May 2017
Co-creator of CANTAB (Cambridge Neuropsychological Test Automated Battery) Professor Trevor Robbins is to receive the Gold Medal Award on May 19, 2017, at the 72nd Annual Meeting in San Diego, California. The award honours pioneering contributions in the field of biological psychiatry and significant and sustained work that extends knowledge in the field.